T. Rowe Price Associates
GILD icon

T. Rowe Price Associates’s Gilead Sciences GILD Stock Holding History

T. Rowe Price Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.66B Sell
26,248,108
-1,450,552
-5% -$203M 0.42% 36
2025
Q4 		$3.4B Buy
27,698,660
+1,195,269
+5% +$145M 0.37% 47
2025
Q3 		$2.94B Buy
26,503,391
+2,916,699
+12% +$332M 0.31% 55
2025
Q2 		$2.62B Buy
23,586,692
+8,883,589
+60% +$945M 0.3% 60
2025
Q1 		$1.65B Buy
14,703,103
+11,156,382
+315% +$1.15B 0.2% 94
2024
Q4 		$328M Buy
3,546,721
+198,528
+6% +$17.9M 0.04% 332
2024
Q3 		$281M Buy
3,348,193
+502,765
+18% +$38.4M 0.03% 367
2024
Q2 		$195M Buy
2,845,428
+352,914
+14% +$23.6M 0.02% 420
2024
Q1 		$183M Sell
2,492,514
-328,986
-12% -$25.3M 0.02% 436
2023
Q4 		$229M Buy
2,821,500
+550,974
+24% +$42.9M 0.03% 394
2023
Q3 		$170M Sell
2,270,526
-851,119
-27% -$65.5M 0.02% 422
2023
Q2 		$241M Buy
3,121,645
+644,251
+26% +$51.4M 0.03% 367
2023
Q1 		$206M Buy
2,477,394
+67,356
+3% +$5.58M 0.03% 378
2022
Q4 		$207M Buy
2,410,038
+756,984
+46% +$59.9M 0.03% 373
2022
Q3 		$102M Sell
1,653,054
-404,237
-20% -$25.5M 0.02% 486
2022
Q2 		$127M Sell
2,057,291
-444,414
-18% -$27.5M 0.02% 593
2022
Q1 		$149M Sell
2,501,705
-228,171
-8% -$14.6M 0.02% 617
2021
Q4 		$198M Sell
2,729,876
-854,995
-24% -$58.9M 0.02% 558
2021
Q3 		$250M Sell
3,584,871
-1,649,613
-32% -$116M 0.02% 475
2021
Q2 		$360M Sell
5,234,484
-173,266
-3% -$11.6M 0.03% 412
2021
Q1 		$350M Sell
5,407,750
-1,003,010
-16% -$64.7M 0.04% 405
2020
Q4 		$373M Sell
6,410,760
-1,671,331
-21% -$101M 0.04% 382
2020
Q3 		$511M Sell
8,082,091
-764,496
-9% -$53M 0.06% 298
2020
Q2 		$681M Sell
8,846,587
-2,233,872
-20% -$171M 0.09% 242
2020
Q1 		$828M Buy
11,080,459
+120,795
+1% +$8.35M 0.13% 162
2019
Q4 		$712M Sell
10,959,664
-173,935
-2% -$11.3M 0.09% 239
2019
Q3 		$706M Sell
11,133,599
-975,934
-8% -$63.8M 0.1% 218
2019
Q2 		$818M Buy
12,109,533
+90,251
+0.8% +$5.94M 0.11% 196
2019
Q1 		$781M Sell
12,019,282
-1,409,257
-10% -$93.7M 0.11% 189
2018
Q4 		$840M Sell
13,428,539
-1,121,117
-8% -$78.4M 0.14% 152
2018
Q3 		$1.12B Sell
14,549,656
-1,717,155
-11% -$130M 0.16% 140
2018
Q2 		$1.15B Sell
16,266,811
-1,152,498
-7% -$81.4M 0.18% 130
2018
Q1 		$1.31B Buy
17,419,309
+101,981
+0.6% +$8.11M 0.21% 109
2017
Q4 		$1.24B Sell
17,317,328
-1,246,673
-7% -$94.7M 0.2% 114
2017
Q3 		$1.5B Buy
18,564,001
+3,587,910
+24% +$274M 0.26% 93
2017
Q2 		$1.06B Buy
14,976,091
+1,787,305
+14% +$119M 0.19% 123
2017
Q1 		$896M Buy
13,188,786
+420,424
+3% +$29.6M 0.17% 146
2016
Q4 		$914M Sell
12,768,362
-1,503,099
-11% -$112M 0.18% 134
2016
Q3 		$1.13B Sell
14,271,461
-2,484,219
-15% -$202M 0.23% 105
2016
Q2 		$1.4B Sell
16,755,680
-10,327,901
-38% -$917M 0.3% 74
2016
Q1 		$2.49B Sell
27,083,581
-12,143,707
-31% -$1.1B 0.53% 34
2015
Q4 		$3.97B Buy
39,227,288
+217,362
+0.6% +$22.6M 0.83% 16
2015
Q3 		$3.83B Sell
39,009,926
-4,303,477
-10% -$478M 0.85% 14
2015
Q2 		$5.07B Sell
43,313,403
-3,536,170
-8% -$386M 1.04% 12
2015
Q1 		$4.6B Sell
46,849,573
-4,751,945
-9% -$483M 0.95% 12
2014
Q4 		$4.86B Sell
51,601,518
-7,311,805
-12% -$756M 1.03% 8
2014
Q3 		$6.27B Sell
58,913,323
-8,083,294
-12% -$792M 1.37% 3
2014
Q2 		$5.55B Sell
66,996,617
-6,908,810
-9% -$538M 1.2% 4
2014
Q1 		$5.24B Sell
73,905,427
-3,965,026
-5% -$311M 1.18% 3
2013
Q4 		$5.85B Buy
77,870,453
+1,587,583
+2% +$111M 1.34% 4
2013
Q3 		$4.79B Sell
76,282,870
-2,194,239
-3% -$131M 1.2% 4
2013
Q2 		$4.02B Buy
+78,477,109
New +$4.09B 1.07% 5

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates's GILD Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Gilead Sciences (GILD) stake by 5.2% in Q1 2026, selling an estimated $203M and leaving 26,248,108 shares worth $3.66B. The position accounts for 0.42% of the portfolio, ranked #36.

T. Rowe Price Associates first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.27B in Q3 2014. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • T. Rowe Price Associates held 26,248,108 shares of Gilead Sciences worth $3.66B as of Q1 2026.
  • T. Rowe Price Associates sold 1,450,552 Gilead Sciences shares in Q1 2026, an estimated $203M.
  • Gilead Sciences made up 0.42% of T. Rowe Price Associates's portfolio in Q1 2026, its #36 holding.
  • T. Rowe Price Associates first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Gilead Sciences position peaked at $6.27B in Q3 2014.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.